Humanised anti-mag antibody or functional fragment thereof

Details Humanised anti-mag antibody or functional fragment thereof Humanised anti-mag antibody or functional fragment thereof

2003-08-05

2009-11-03

Ewoldt, G. R (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C424S145100, C514S903000

Reexamination Certificate

active

07612183

ABSTRACT:
The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.

REFERENCES:
patent: 5250414 (1993-10-01), Schwab et al.
patent: 5792743 (1998-08-01), Schachner
patent: 5932542 (1999-08-01), Filbin
patent: 6203792 (2001-03-01), Filbin
patent: 6399577 (2002-06-01), Filbin
patent: 6548061 (2003-04-01), Steeves et al.
patent: 6576607 (2003-06-01), Schachner
patent: 2004/0002790 (2004-01-01), Senn
patent: 2004/0170627 (2004-09-01), Irving et al.
patent: 2006/0165681 (2006-07-01), Ellis et al.
patent: 2007/0269427 (2007-11-01), Irving et al.
patent: 2008/0014195 (2008-01-01), Irving et al.
patent: 1264885 (2001-02-01), None
patent: WO 95/22344 (1995-08-01), None
patent: 96/32959 (1996-10-01), None
patent: 97/01352 (1997-01-01), None
patent: 97/07810 (1997-03-01), None
patent: 98/12329 (1998-03-01), None
patent: WO 95/12329 (1998-03-01), None
patent: WO 9812329 (1998-03-01), None
patent: WO 99/25378 (1999-05-01), None
patent: WO 99/53945 (1999-10-01), None
patent: 00/05364 (2000-02-01), None
patent: 00/31235 (2000-06-01), None
patent: 00/43039 (2000-07-01), None
patent: 00/63252 (2000-10-01), None
patent: WO 01/62907 (2001-08-01), None
patent: WO 02/062383 (2002-08-01), None
patent: 2004/014953 (2004-02-01), None
Lamminmaki, U., et al. J. Biol. Chem. 2001;276(39):36687-36694.
De Pascalis, R., et al. 2002;169:3076-3084.
U.S. Appl. No. 12/060,555, filed Apr. 1, 2008, Ellis, et al.
Bartsch, et al., Neuron, vol. 15 pp. 1375-1381 (1995).
Belayev, et al., Brain Research, vol. 739 pp. 88-96 (1996).
Bickel, et al., Advanced Drug Delivery Reviews, vol. 46 pp. 247-274 (1996).
Birch and Lenox, Monoclonal Antibodies: Principles and Applications, John Wilet and Sons Inc. pp. 299-335 (1995).
Chen, et al., Nature vol. 403 (6768) pp. 434-439 (2000).
Chothia et al., Nature, vol. 342 pp. 877-883 (1989).
Coloma, et al., Pharma Research, vol. 17(3) pp. 266-276 (2000).
DeBellard, et al., Mol. Cell. Neurosci., vol. 7(2) pp. 89-101 (1996).
Depascalis, et al., J. Immunology, vol. 169 pp. 3076-3084 (2002).
Grandpre, et al., Nature, vol. 403(6768) pp. 439-444 (2000).
Irving et al., J. of Cerebral Blood Flow & Metabolism, vol. 17 pp. 612-622 (1997).
Jakeman, et al., Exp. Neurol., vol. 154(1) pp. 170-184 (1998).
Kastrup, et al., Journal of the Neurological Sciences, vol. 166 pp. 91-99 (1999).
Kawamata, et al., Proc. Natl. Acad. Sci. USA, vol. 94(15) pp. 8179-8184.
Lamminmaki, et al., J. Bio. Chem., vol. 276(39) pp. 36687-36694 (2001).
Lassmann, et al., GLIA, vol. 19(2) pp. 104-110 (1997).
Li, et al., J. of Neurosci. Research, vol. 46(4) pp. 404-414 (1996).
Li, et al., J. of Neurosci. Research, vol. 51(2) pp. 210-217 (1998).
Li, et al., Nature, vol. 369(6483) pp. 747-750 (1994).
Lopate, et al., J. Neurol. Sci., vol. 188(1-2) pp. 67-72 (2001).
Lunn, et al., Brain, vol. 125 pp. 904-911 (2002).
Matsuo, et al., Stroke, vol. 32 pp. 2143-2148 (2001).
McKerracher, et al., Neuron, vol. 13 pp. 805-811 (1994).
Montag, et al, Neuron, vol. 13 pp. 229-246 (1994).
Mukhopadhyay, et al., Neuron. vol. 13 pp. 757-767 (1994).
Niederost et al., J. of Neuroscience, vol. 22(23) pp. 10368-10376 (2002).
Poltorak, et al., J. of Cell Biology, vol. 105(4) pp. 1893-1899 (1987).
Prinjha, et al., Nature, vol. 403(6768) pp. 383-384 (2000).
Ribotta, et al., J. Neurosci., vol. 20(13) pp. 5144-5152 (2000).
Sato, et al., Biochem. Biophys. Res. Comm., vol. 163(3) pp. 1473-1480 (1989).
Schafer, et al., Neuron, vol. 16(6) pp. 1107-1113 (1996).
Somogyvari-Vigh, et al., Regulatory Peptides, vol. 91 pp. 89-95 (2000).
Tang, et al., Mol. Cell. Neurosci., vol. 9(5-6) pp. 333-346 (1997).
Torigoe, et al., Exp. Neurology, vol. 150(2) pp. 254-262 (1997).
Umemori et al., Nature, vol. 367 pp. 572-576 (1994).
Valeriani et al., J. of Cerebral Blood Flow & Metabolism, vol. 20 pp. 765-771 (2000).
Vinson et al., Molecular and Cellular Neuroscience, vol. 22 pp. 344-352 (2003).
Wong et al., Nature Neuroscience, vol. 5(12) pp. 1302-1306 (2002).
Yin, et al., J. Neurosci., vol. 18(6) pp. 1953-1962 (1998).

Affiliated with

Also associated with

Rating

Humanised anti-mag antibody or functional fragment thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Humanised anti-mag antibody or functional fragment thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanised anti-mag antibody or functional fragment thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4143994